UAE Approves New Oral Therapy for Breast Cancer Patients

Women with advanced breast cancer who run out of treatment options now have renewed hope, thanks to a medical breakthrough approved in the UAE.

The Emirates Drug Establishment (EDE) announced Thursday it has approved Etcamah, an innovative oral therapy for patients with advanced or metastatic breast cancer who developed resistance to hormone therapy. The UAE is the first country in the world to greenlight this treatment.

The therapy works by blocking and breaking down estrogen receptors in cancer cells, which slows tumor growth and prevents the disease from spreading. This approach tackles a critical challenge: what happens when standard hormone therapies stop working.

Etcamah earned approval after demonstrating strong results in the Phase III SERENA-6 trial. Patients who had developed mutations while receiving standard endocrine therapy showed significant improvements in progression-free survival, meaning they lived longer without their cancer worsening.

Dr. Fatima Al Kaabi, Director-General of the Emirates Drug Establishment, said the approval strengthens the UAE's ability to offer cutting-edge treatment options. "Through advanced assessment tools that balance accelerated access with the highest standards of safety and quality, we will continue to reinforce the UAE's position as a trusted reference point for pharmaceutical innovation," she said.

The Ripple Effect

This approval extends beyond individual patients. Breast cancer remains one of the most common cancers among women worldwide, making expanded treatment access crucial for improving outcomes and quality of life across entire communities.

The EDE emphasized that while new therapies offer hope, early detection remains vital. Regular screenings, sticking to prescribed treatment plans, and maintaining consistent follow-up with healthcare professionals all play essential roles in improving treatment response and recovery outcomes.

By fast-tracking this approval, the UAE demonstrates how regulatory innovation can speed life-saving treatments to patients who need them most. The country's position as the first to approve Etcamah may pave the way for faster approvals elsewhere, potentially helping breast cancer patients around the globe gain access to this therapy sooner.

For women facing advanced breast cancer, this new oral therapy represents something precious: another chance when previous options have failed.